BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in ALXO — Alx Oncology Holdings Inc

CIK 1107261 HOUSTON, TX

Position in ALXO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$152,524

+$66,563 QoQ

Shares Held

76,072

0.0% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 68 holders

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $58,876,414 across 111 Biotechnology names. ALXO ranks #83 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	528,698	$8,697,082
2	PBYI	Puma Biotechnology, Inc.	775,341	$4,954,428
3	EXEL	Exelixis, Inc.	66,100	$2,835,029
4	KROS	Keros Therapeutics, Inc.	195,017	$2,152,987
5	SGMT	Sagimet Biosciences Inc.	299,641	$1,565,624
6	BDTX	Black Diamond Therapeutics, Inc.	723,477	$1,541,006
7	PTCT	Ptc Therapeutics, Inc.	22,000	$1,498,860
8	KYTX	Kyverna Therapeutics, Inc.	149,900	$1,293,637

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$152,524	76,072	0.0%	Shares	Sole	2026-05-15
2025-12-31	$85,961	76,072	+111.3%	Shares	Sole	2026-02-17
2025-09-30	$65,880	36,000	-52.0%	Shares	Sole	2025-11-14
2024-12-31	$125,250	75,000	+275.0%	Shares	Sole	2025-02-14
2024-03-31	$223,000	20,000	-40.3%	Shares	Sole	2024-05-15
2023-12-31	$498,815	33,500	-30.9%	Shares	Sole	2024-02-14
2023-09-30	$232,800	48,500	0.0%	Shares	Sole	2023-11-14
2023-06-30	$364,235	48,500	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.